0001178913-26-004122 Sample Contracts
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 13th, 2026 • Silexion Therapeutics Corp • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August 11, 2026, between Silexion Therapeutics Corp, a Cayman Islands corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PRE-FUNDED ORDINARY SHARE PURCHASE WARRANTPre-Funded Ordinary Share Purchase Warrant • August 13th, 2026 • Silexion Therapeutics Corp • Biological products, (no disgnostic substances) • New York
THIS PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until this Warrant is exercised in full(the “Termination Date”) but not thereafter, to subscribe for and purchase from Silexion Therapeutics Corp, a Cayman Islands corporation (the “Company”), up to ______ Ordinary Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PLACEMENT AGENT ORDINARY SHARE PURCHASE WARRANTPlacement Agent Ordinary Share Purchase Warrant • August 13th, 2026 • Silexion Therapeutics Corp • Biological products, (no disgnostic substances) • New York
THIS PLACEMENT AGENT ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on August 11, 2031 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Silexion Therapeutics Corp, a Cayman Islands corporation (the “Company”), up to ______ Ordinary Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, dated as of September 8, 2024, as amended January 29, 2025, March 24, 2025 and May 15, 2026, by and between the Company and H.C. Wainwright & Co., LLC, as amended.
SERIES E ORDINARY SHARE PURCHASE WARRANT SILEXION THERAPEUTICS CORPWarrant Agreement • August 13th, 2026 • Silexion Therapeutics Corp • Biological products, (no disgnostic substances) • New York
THIS SERIES E ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the date that is the five (5) year anniversary of the Initial Exercise Date, provided that, if such date is not a Trading Day, the date that is the immediately following Trading Day (the “Termination Date”) but not thereafter, to subscribe for and purchase from Silexion Therapeutics Corp, a Cayman Islands corporation (the “Company”), up to ______ Ordinary Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).